Company News

Symrise Takes Stake in U.S. BioTech Firm

Author Image

By: TOM BRANNA

Editor

Symrise has acquired a 20% stake Therapeutic Peptides Inc. (TPI), a New Orleans, LA-based biotechnology company, giving it exclusive distribution rights for advanced cosmetic active ingredients, including peptides. “We are delighted to be able to integrate these modern and very effective ingredients in our portfolio. With TPI, we have found a partner who is developing these ingredients at a scientifically exalted level and can offer ample expertise in this field,” said Dr. Klaus Stanzl, presi...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters